ADCT: ADC Therapeutics SA Stock

by  •  • Comments Off on ADCT: ADC Therapeutics SA Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 147.63
Enterprise Value ($M) 337.71
Book Value ($M) -202.64
Book Value / Share -2.05
Price / Book -0.73
NCAV ($M) -217.23
NCAV / Share -2.19
Price / NCAV -0.68

Profitability (mra)
Return on Invested Capital (ROIC) -0.64
Return on Assets (ROA) -0.51
Return on Equity (ROE) n/a

Liquidity (mrq)
Quick Ratio 3.59
Current Ratio 3.82

Balance Sheet (mrq) ($M)
Current Assets 307.39
Assets 321.98
Liabilities 524.62
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 70.84
Operating Income -130.65
Net Income -157.85

Cash Flow Statement (mra) ($M)
Cash From Operations -123.83
Cash from Investing -0.87
Cash from Financing 97.05

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-14 13G Orbimed Advisors Llc 3.60
02-03 13G BlackRock, Inc. 5.20
11-14 13G/A Redmile Group, LLC 16.20 2.22
11-13 13G/A Prosight Management, LP 9.96 48.75
05-03 13G Oaktree Capital Group Holdings GP, LLC 5.19
04-25 13D/A Auven Therapeutics Holdings Lp 2.70 -64.37

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-03-27 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2024-11-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-08-06 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-05-06 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-03-31 149,608 474,504 31.53
2025-03-28 85,679 216,837 39.51
2025-03-27 139,600 465,873 29.97

(click for more detail)

Similar Companies
ABBV – AbbVie Inc. ABT – Abbott Laboratories
ANRO – Alto Neuroscience, Inc. ANVS – Annovis Bio, Inc.


Financial data and stock pages provided by
Fintel.io